A phase 2 study of BPM31510 (a lipid nanodispersion of oxidized CoQ10) with vitamin K in combination with standard of care (SOC) RT and TMZ in glioblastoma multiforme (GBM) patients without prior therapy

ubidecarenone IV (BPM31510 IV) - BPGbio

https://www.abstractsonline.com/pp8/#!/20273/presentation/10611

Brian Stocksdale1; Rebecca Brown2; Kevin Elmore2; Chirag Patel3; Adam Cohen4; Rupa Juthani5; Brian Vaillant6; Alexander Spira7; Jedrzej Wykretowicz8; Bing Nie9; Michael A. Kiebish9; Stephane Gesta9; Niven R. Narain9; Vijay Modur9; Seema Nagpal1

Mar 26, 2025